How ORILISSA works

A next step for moderate to severe endometriosis pain



The first FDA-approved oral treatment for moderate to severe endometriosis pain in over a decade1


GnRH antagonist
mechanism of action

Learn about the GnRH receptor
antagonism mechanism of
action (MOA).1

Pharmacology

Learn about the pharmacologic properties of ORILISSA.



ORILISSA dosing

Dosing information for the two
available oral formulations.1

150 mg QD   200 mg BID

Patient Profiles

Peer dosing case studies and a customizable patient profile.

Back to top